JP2024516110A5 - - Google Patents
Info
- Publication number
- JP2024516110A5 JP2024516110A5 JP2023562191A JP2023562191A JP2024516110A5 JP 2024516110 A5 JP2024516110 A5 JP 2024516110A5 JP 2023562191 A JP2023562191 A JP 2023562191A JP 2023562191 A JP2023562191 A JP 2023562191A JP 2024516110 A5 JP2024516110 A5 JP 2024516110A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- weight
- optionally
- bacteria
- pharmaceutical product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163172370P | 2021-04-08 | 2021-04-08 | |
| US63/172,370 | 2021-04-08 | ||
| US202163197000P | 2021-06-04 | 2021-06-04 | |
| US63/197,000 | 2021-06-04 | ||
| PCT/US2022/023979 WO2022217030A1 (en) | 2021-04-08 | 2022-04-08 | Pharmaceutical composition containing bacteria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516110A JP2024516110A (ja) | 2024-04-12 |
| JP2024516110A5 true JP2024516110A5 (enExample) | 2025-04-15 |
Family
ID=81581166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562191A Pending JP2024516110A (ja) | 2021-04-08 | 2022-04-08 | 細菌を含有する医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250073285A1 (enExample) |
| EP (1) | EP4319723A1 (enExample) |
| JP (1) | JP2024516110A (enExample) |
| KR (1) | KR20240006543A (enExample) |
| TW (1) | TW202304415A (enExample) |
| WO (1) | WO2022217030A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3102263A1 (en) * | 2018-06-07 | 2019-12-12 | Artugen Therapeutics Ltd. | Methods and compositions for the treatment of c. difficile |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775536A (en) | 1986-02-24 | 1988-10-04 | Bristol-Myers Company | Enteric coated tablet and process for making |
| US5292522A (en) | 1989-06-20 | 1994-03-08 | Rohm Gmbh | Aqueous film coating agent for solid medicaments |
| US5047258A (en) | 1989-07-14 | 1991-09-10 | Sterling Drug Inc. | Aqueous spray-coating process |
| US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| DE19631084A1 (de) | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut |
| US6312728B1 (en) | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
| EP1101490B1 (en) | 1998-07-28 | 2005-04-13 | Tanabe Seiyaku Co., Ltd. | Preparation capable of releasing drug at target site in intestine |
| US20040028737A1 (en) | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
| DE10260919A1 (de) | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
| CA2543172A1 (en) | 2003-10-31 | 2005-05-19 | Dexcel Ltd. | Stable lansoprazole formulation |
| US9149439B2 (en) | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
| DE102005032806A1 (de) | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
| ES2425385T3 (es) * | 2009-04-30 | 2013-10-15 | Actogenix N.V. | Crioprotectores para la liofilización de las bacterias de ácido láctico |
| CN105142616B (zh) | 2013-03-01 | 2018-02-13 | Bpsi控股有限责任公司 | 含有硅酸钙的延迟释放薄膜包衣及其包被的底物 |
| JP2020523326A (ja) | 2017-06-14 | 2020-08-06 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | 細菌株を含む組成物 |
| KR102563191B1 (ko) * | 2017-07-05 | 2023-08-02 | 에벨로 바이오사이언시즈, 인크. | 비피도박테리움 애니멀리스 ssp. 락티스를 이용한 암 치료 조성물 및 방법 |
| GB2564481B (en) * | 2017-07-14 | 2019-10-23 | 4D Pharma Leon S L U | Process |
| US11090341B2 (en) * | 2018-02-06 | 2021-08-17 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and immune disorders using Veillonella bacteria |
| US20210205378A1 (en) * | 2018-05-31 | 2021-07-08 | Hokukon Co., Ltd. | Lactic acid bacteria and use thereof |
| CA3102263A1 (en) | 2018-06-07 | 2019-12-12 | Artugen Therapeutics Ltd. | Methods and compositions for the treatment of c. difficile |
| WO2020120714A1 (en) | 2018-12-12 | 2020-06-18 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| IT201900006056A1 (it) * | 2019-04-18 | 2020-10-18 | Probiotical Spa | Procedimento per la preparazione di una biomassa di cellule di batteri liofilizzate stabili e determinazione della loro stabilità mediante un metodo citofluorimetrico |
| CA3143994A1 (en) * | 2019-06-21 | 2020-12-24 | Evelo Biosciences, Inc. | Compositions and methods of treating a th2-mediated condition using prevotella |
| CN110251474B (zh) * | 2019-07-15 | 2022-01-07 | 北京工商大学 | 一种淀粉基大肠靶向双层益生菌片的制备方法 |
| WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
-
2022
- 2022-04-08 TW TW111113512A patent/TW202304415A/zh unknown
- 2022-04-08 EP EP22721538.1A patent/EP4319723A1/en not_active Withdrawn
- 2022-04-08 WO PCT/US2022/023979 patent/WO2022217030A1/en not_active Ceased
- 2022-04-08 KR KR1020237038507A patent/KR20240006543A/ko active Pending
- 2022-04-08 JP JP2023562191A patent/JP2024516110A/ja active Pending
- 2022-04-08 US US18/285,890 patent/US20250073285A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3752421B2 (ja) | 乳酸菌の安定化のための微細腸溶性コーティング顆粒 | |
| JP2023510158A5 (enExample) | ||
| US20150050245A1 (en) | Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora | |
| TWI584824B (zh) | A capsule for delivery to a large intestine and a method of manufacturing the same | |
| US20060127489A1 (en) | Targeted delivery | |
| JP2018518478A (ja) | エタノールの影響に対する耐性を有する医薬品組成物または栄養機能食品組成物 | |
| US10016467B2 (en) | Formulations of viable cells for oral delivery | |
| KR101686176B1 (ko) | 내산성 및 안정성이 향상된 프로바이오틱스 코팅 고체 조성물의 제조 방법 | |
| Muvva et al. | Modified pectins for colon-specific drug delivery | |
| EP3646857A1 (en) | Colonic delivery system for microorganisms | |
| RU2008120672A (ru) | Композиции для перорального введения, содержащие тайгециклин | |
| Brachkova et al. | Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage forms | |
| JP5957280B2 (ja) | 大腸デリバリーシームレスカプセル製剤及びその製造方法 | |
| JP5940869B2 (ja) | 腸内環境改善有核錠製剤及びハードカプセル製剤 | |
| TWI374035B (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
| CN100518830C (zh) | 变性淀粉口服结肠靶向控释薄膜包衣材料及其制备方法和制备包衣材料的应用 | |
| CN218165648U (zh) | 一种保持益生菌活性的制剂 | |
| WO2021152869A1 (ja) | 腸溶性組成物、該腸溶性組成物を含む飲食品、該腸溶性組成物の崩壊時間を制御する方法、及び該腸溶性組成物の製造方法 | |
| Lalani et al. | Applications of polymers in small intestinal drug delivery | |
| GB2394416A (en) | Targeted delivery of microbially encapsulated drugs | |
| KR20250004712A (ko) | 하나 이상의 방출 촉진제를 포함하는 이중 코팅 시스템을 사용한 pH 3 내지 6 에서 약물 방출을 갖는 투여 형태 | |
| US20240189236A1 (en) | Composition comprising a (meth)acrylate copolymer, an alkali or ammonium salt of a saturated aliphatic monocarboxylic acid and specific glidants | |
| EP4366708A1 (en) | Hard shell capsules having improved colon release | |
| KR20240158254A (ko) | pH 값 5 내지 5.5 에서 약물 방출이 가속화되는 사전 기능화된 경질 쉘 캡슐 | |
| Alekseev et al. | Polymers in the formulation of drug dosage forms with modified release |